Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
Location: Boston MA, New Brunswick NJ, Hershey PA, Akron OH,
Sponsor: Anagram Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT07450547
Phase 2, Recruiting
Active & Responsive
Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
for
Stress Disorders, Post-Traumatic
Location: Decatur GA
Sponsor: Emory University
Sex: All
Age: 18 - 65
Code: NCT02560805
Phase 2, Recruiting
Active & Responsive
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
for
Hypoparathyroidism, Endocrine System Diseases,
Location: New York NY, New Brunswick NJ, Greenville NC,
Sponsor: Ascendis Pharma Bone Diseases A/S
Sex: All
Age: 18+
Code: NCT07081997
Phase 3, Recruiting
Active & Responsive
Neurocognitive Ankle Training for Instability to Optimize Neuromusculoskeletal Outcomes (NATION)
for
Chronic Ankle Instability
Location: Fort Bragg NC, Lexington KY
Sponsor: Womack Army Medical Center
Sex: All
Age: 18 - 44
Code: NCT06527287
Recruiting
Active & Responsive
Empower EI: Comparing Early Intervention Approaches to Improve Communication in Toddlers With Developmental Delays